{"symbol": "RFL", "companyName": "Rafael Holdings Inc. Class B", "exchange": "NYSE American", "industry": "Biotechnology", "website": "http://www.rafaelholdings.com", "description": "Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells.", "CEO": "Howard S. Jonas", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}